Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New oral cancer drug targets rare salivary gland tumors

NCT ID NCT06118086

Summary

This study is testing a new oral medication called REM-422 for people with advanced adenoid cystic carcinoma (ACC), a rare type of cancer often found in salivary glands. The trial aims to find the safest and most effective dose and see if the drug can shrink tumors or slow cancer growth. About 100 adults with recurrent, metastatic, or inoperable ACC will take the medication until their cancer progresses or they experience side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADENOID CYSTIC CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Antoine Lacassagne

    NOT_YET_RECRUITING

    Nice, 06189, France

    Contact

  • Dana Farber Cancer Research Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

    Contact

  • Institut de Cancerologie Gustave-Roussy

    NOT_YET_RECRUITING

    Villejuif, 94805, France

    Contact

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

    Contact

  • Sarah Cannon Research Institute

    RECRUITING

    Nashville, Tennessee, 37203, United States

    Contact

  • University of California San Francisco Helen Diller Comprehensive Cancer Center

    RECRUITING

    San Francisco, California, 94143, United States

    Contact

  • University of Michigan Rogel Cancer Center

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

    Contact

Conditions

Explore the condition pages connected to this study.